APOB and inherited lipid metabolism disorder: This is particularly pertinent for patients with type 2 DM in whom their dyslipidaemia is typically characterized by elevated triglycerides, low HDL and smaller denser LDL-C with proportionally higher levels of atherogenic ApoB lipoproteins not in the LDL sub-fraction, reflecting a pro-atherogenic lipid phenotype.1